Abstract
Gene and small interfering ribonucleic acid (siRNA) therapies are applicable to a wide range of diseases; diseases where a mutated gene is the basis for the disease, e.g. cystic fibrosis, haemophilia and cancer. However, there are some difficulties with gene and siRNA therapy, i.e. low gene and siRNA internalisation into the cells, instability of the nucleic acid molecule in the cell and the lack of specific gene targeting to the nucleus. Although physical methods exist to deliver naked deoxyribonucleic acid (DNA) into cell nuclei, these methods are inefficient and hence nucleic acid vectors are used. These delivery vectors are viruses, cationic polymers and dendrimers or cationic liposomes; with the synthetic vectors all possessing a mandatory amine functional group. Viral vectors are the most efficient gene vectors and there are currently three licenced products available: Rexin G for the treatment of malignant solid tumours, Gendicine for the treatment of head and neck cancer and Glybera for the treatment of lipoprotein lipase deficiency; these three are gene therapies involving viral vectors. Other nucleic acid delivery vectors that are still in development include amine polymers, dendrimers and liposomes prepared from amine phospholipids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balazs DA, Godbey W (2011) Liposomes for use in gene delivery. J Drug Deliv 2011:326497
Bell HS, Dufes C, O’Prey J, Crighton D, Bergamaschi D, Lu X, Schatzlein AG, Vousden KH, Ryan KM (2007) A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo. J Clin Invest 117:1008–1018
Bragonzi A, Boletta A, Biffi A, Muggia A, Sersale G, Cheng SH, Bordignon C, Assael BM, Conese M (1999) Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Ther 6:1995–2004
Brown MD, Schatzlein A, Brownlie A, Jack V, Wang W, Tetley L, Gray AI, Uchegbu IF (2000) Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. Bioconjug Chem 11:880–891
Brown MD, Schatzlein A, Uchegbu IF (2001) Gene delivery with synthetic (non viral) carriers. Int J Pharm 229:1–21
Brown MD, Gray AI, Tetley L, Santovena A, Rene J, Schatzlein AG, Uchegbu IF (2003) In vitro and in vivo gene transfer with poly(amino acid) vesicles. J Control Release 93:193–211
Brownlie A, Uchegbu IF, Schatzlein AG (2004) PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility. Int J Pharm 274:41–52
Bruno M (2010) Gene therapy coming of age—prevention of acute pancreatitis in lipoprotein lipase deficiency through alipogene tiparvovec. Eur J Gastroenterol Hepatol Rev 6:48–53
Budker VG, Subbotin VM, Budker T, Sebestyen MG, Zhang G, Wolff JA (2006) Mechanism of plasmid delivery by hydrodynamic tail vein injection. II. Morphological studies. J Gene Med 8:874–888
Buning H, Perabo L, Coutelle O, Quadt-Humme S, Hallek M (2008) Recent developments in adeno-associated virus vector technology. J Gene Med 10:717–733
Bunz F (2008) Principles of cancer genetics. Springer, New York
Caplen NJ, Alton EWFW, Middleton PG, Dorin JR, Stevenson BJ, Gao X, Durham SR, Jeffery PK, Hodson ME, Coutelle C, Huang L, Porteous DJ, Williamson R, Geddes DM (1995) Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1:39–46
Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669–672
Chisholm EJ, Vassaux G, Martin-Duque P, Chevre R, Lambert O, Pitard B, Merron A, Weeks M, Burnet J, Peerlinck I, Dai M-S, Alusi G, Mather SJ, Bolton K, Uchegbu IF, Schatzlein AG, Baril P (2009) Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res 69:2955–2962
Chooi KW, Gray AI, Tetley L, Fan YL, Uchegbu IF (2010) The molecular shape of poly(propylenimine) dendrimers has a profound effect on their self assembly. Langmuir 26:2301–2316
Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA, Yen Y, Heidel JD, Ribas A (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464:1067–1070
Driskell RA, Engelhardt JF (2003) Current status of gene therapy for inherited lung diseases. Annu Rev Physiol 65:585–612
Dufes C, Keith WN, Bilsland A, Proutski I, Uchegbu JF, Schatzlein AG (2005a) Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Res 65:8079–8084
Dufes C, Uchegbu IF, Schatzlein AG (2005b) Dendrimers in gene delivery. Adv Drug Deliv Rev 57:2177–2202
Dufes C, Uchegbu IF, Schatzlein AG (2006) Dendrimers in drug and gene delivery. In: Uchegbu IF, Schatzlein AG (eds) Polymers in drug delivery. CRC Press, Boca Raton, FL, pp 199–236
Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215–2237
El-Aneed A (2004) An overview of current delivery systems in cancer gene therapy. J Control Release 94:1–14
Even-Chen S, Cohen R, Barenholz Y (2012) Factors affecting DNA binding and stability of association to cationic liposomes. Chem Phys Lipids 165:414–423
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84:7413–7417
Florea BI, Meaney C, Junginger HE, Borchard G (2002) Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. AAPS PharmSci 4:E12
Gary DJ, Puri N, Won YY (2007) Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release 121:64–73
Gaudet D, de Wal J, Tremblay K, Déry S, van Deventer S, Freidig A, Brisson D, Méthot J (2010) Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency. Atheroscler Suppl 11:55–60
Gill DR, Southern KW, Mofford KA, Seddon T, Huang L, Sorgi F, Thomson A, MacVinish LJ, Ratcliff R, Bilton D, Lane DJ, Littlewood J, Webb M, Middleton PG, Colledge WH, Cuthbert AW, Evans MJ, Higgins CF, Hyde SC (1997) A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4:199–209
Godbey WT, Mikos AG (2001) Recent progress in gene delivery using non-viral transfer complexes. J Control Release 72:115–125
Godbey WT, Wu KK, Mikos AG (1999) Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 45:268–275
Gordon EM, Chen ZH, Liu L, Whitley M, Wei D, Groshen S, Hinton DR, Anderson WF, Beart RW Jr, Hall FL (2001) Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice. Hum Gene Ther 12:193–204
Gordon EM, Chan MT, Geraldino N, Lopez FF, Cornelio GH, Lorenzo CC III, Levy JP, Reed RA, Liu L, Hall FL (2007) Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes. Int J Oncol 30:1297–1307
Guo X, Huang L (2012) Recent advances in nonviral vectors for gene delivery. Acc Chem Res 45:971–979
Haensler J (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem 4:372
Herweijer H, Wolff JA (2007) Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther 14:99–107
Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K, Chatters SJ, de Ridder D, Gilmour KC, Adams S, Thornhill SI, Parsley KL, Staal FJ, Gale RE, Linch DC, Bayford J, Brown L, Quaye M, Kinnon C, Ancliff P, Webb DK, Schmidt M, von Kalle C, Gaspar HB, Thrasher AJ (2008) Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118:3143–3150
Huang L, Hung MC, Wagner E (2005) Nonviral vectors for gene therapy. Elsevier Academic Press, San Diego, CA
Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7:33–40
Kelly TJ (1984) Adenovirus DNA replication. In: Ginsberg HS (ed) The adenoviruses, vol 1. Plenum, New York, pp 271–308
Kennedy MA, Parks RJ (2009) Adenovirus virion stability and the viral genome: size matters. Mol Ther 17:1664–1666
Kim T-H, Jiang H-L, Jere D, Park I-K, Cho M-H, Nah J-W, Choi Y-J, Akaike T, Cho C-S (2007) Chemical modification of chitosan as a gene carrier in vitro and in vivo. Prog Polym Sci 32:726–753
Kingston HM (1989) ABC of clinical genetics. Gene structure and function. BMJ 298:1629–1631
Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (2001) Fundamental virology. Lippincott Williams & Wilkins, Philadelphia, PA
Koltover I, Salditt T, Radler JO, Safinya CR (1998) An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 281:78–81
Kotin RM, Menninger JC, Ward DC, Berns KI (1991) Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10:831–834
Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR Jr (1996) Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA 93:4897–4902
Lamarque G, Chaussard G, Domard A (2007) Thermodynamic aspects of the heterogeneous deacetylation of â-chitin: reaction mechanisms. Biomacromolecules 8:1942–1950
Lee JH, Lim YB, Choi JS, Lee Y, Kim TI, Kim HJ, Yoon JK, Kim K, Park JS (2003) Polyplexes assembled with internally quaternised PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency. Bioconjug Chem 14:1214–1221
Lungwitz U, Breunig M, Blunk T, Göpferich A (2005) Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 60:247–266
Maeda N, Fan H, Yoshikai Y (2008) Oncogenesis by retroviruses: old and new paradigms. Rev Med Virol 18:387–405
Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R (2000) Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I- 125-labelled polyamidoamine dendrimers in vivo. J Control Release 65:133–148
Manome Y, Nakamura M, Ohno T, Furuhata H (2000) Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo. Hum Gene Ther 11:1521–1528
Midoux P, Monsigny M (1999) Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug Chem 10:406–411
Miller DL, Pislaru SV, Greenleaf JE (2002) Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet 27:115–134
Murphy SL, High KA (2008) Gene therapy for haemophilia. Br J Haematol 140:479–487
Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E (1999) PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 6:595–605
Patil SD, Rhodes DG, Burgess DJ (2005) DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J 7:E61–E77
Peng Z (2005) Current status of Gendicine in China: recombinant Ad-p53 agent for treatment of cancers. Hum Gene Ther 16:1016–1027
Peng SF, Yang MJ, Su CJ, Chen HL, Lee PW, Wei MC, Sung HW (2009) Effects of incorporation of poly(gamma-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency. Biomaterials 30:1797–1808
Persons DA (2010) Lentiviral vector gene therapy: effective and safe? Mol Ther 18:861–862
Pesole G (2008) What is a gene? An updated operational definition. Gene 417:1–4
Porteous DJ, Dorin JR, McLachlan G, DavidsonSmith H, Davidson H, Stevenson BJ, Carothers AD, Wallace WAH, Moralee S, Hoenes C, Kallmeyer G, Michaelis U, Naujoks K, Ho LP, Samways JM, Imrie M, Greening AP, Innes JA (1997) Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4:210–218
Radler JO, Koltover I, Salditt T, Safinya CR (1997) Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 275:810–814
Reitan NK, Maurstad G, de Lange Davies C, Strand SP (2009) Characterizing DNA condensation by structurally different chitosans of variable gene transfer efficacy. Biomacromolecules 10:1508–1515
Rosenecker J, Schmalix WA, Schindelhauer D, Plank C, Reinhardt D (1998) Towards gene therapy of cystic fibrosis. Eur J Med Res 3:149–156
Ross CJ, Twisk J, Meulenberg JM, Liu G, van den Oever K, Moraal E, Hermens WT, Rip J, Kastelein JJ, Kuivenhoven JA, Hayden MR (2004) Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation. Hum Gene Ther 15:906–919
Schatzlein AG, Zinselmeyer BH, Elouzi A, Dufes C, Chim YTA, Roberts CJ, Davies MC, Munro A, Gray AI, Uchegbu IF (2005) Preferential liver gene expression with polypropylenimine dendrimers. J Control Release 101:247–258
Smith L (2002) Gene therapy in the post-Gelsinger era. JONAS Healthc Law Ethics Regul 4:104
Somiari S, Glasspool-Malone J, Drabick JJ, Gilbert RA, Heller R, Jaroszeski MJ, Malone RW (2000) Theory and in vivo application of electroporative gene delivery. Mol Ther 2:178–187
Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, Kinner A, Schmidt M, Kramer A, Schwable J, Glimm H, Koehl U, Preiss C, Ball C, Martin H, Gohring G, Schwarzwaelder K, Hofmann WK, Karakaya K, Tchatchou S, Yang R, Reinecke P, Kuhlcke K, Schlegelberger B, Thrasher AJ, Hoelzer D, Seger R, von Kalle C, Grez M (2010) Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16:198–204
Sukharev SI, Klenchin VA, Serov SM, Chernomordik LV, Chizmadzhev Yu A (1992) Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores. Biophys J 63:1320–1327
Sun X, Zhang N (2010) Cationic polymer optimization for efficient gene delivery. Mini Rev Med Chem 10:108–125
Touchefeu Y, Harrington KJ, Galmiche JP, Vassaux G (2010) Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology. Aliment Pharmacol Ther 32:953–968
Uchegbu IF, Siew A (2013) Nanomedicines and nanodiagnostics come of age. J Pharm Sci 102:305–310
Uchegbu IF, Sadiq L, Pardakhty A, El-Hammadi M, Gray AI, Tetley L, Wang W, Zinselmeyer BH, Schatzlein AG (2004) Gene transfer with three amphiphilic glycol chitosans—the degree of polymerisation is the main controller of transfection efficiency. J Drug Target 12:527–539
Verma IM, Somia N (1997) Gene therapy—promises, problems and prospects. Nature 389:239–242
Waehler R, Russell SJ, Curiel DT (2007) Engineering targeted viral vectors for gene therapy. Nat Rev Genet 8:573–587
Ward CM, Read ML, Seymour LW (2001) Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 97:2221–2229
Weatherall DJ (1995) Scope and limitations of gene therapy. Br Med Bull 51:1–11
Weiss YG, Tazelaar J, Gehan BA, Bouwman A, Christofidou-Solomidou M, Yu QC, Raj N, Deutschman CS (2001) Adenoviral vector transfection into the pulmonary epithelium after cecal ligation and puncture in rats. Anesthesiology 95:974–982
Wilkinson GW, Lowenstein PR (1994) Introduction to gene transfer: viral vectors. Gene Ther 1(Suppl 1):S1–S3
Wilmott RW, Whitsett JA, Trapnell B, Wert S, Baughman R, Cuppoletti J, Tolstohev P (1994) Gene-therapy for cystic-fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic-fibrosis transmembrane conductance regulator cDNA to the airways—a phase-I study. Hum Gene Ther 5:1019–1057
Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465–1468
Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749–1751
Yang PL, Althage A, Chung J, Chisari FV (2002) Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci USA 99:13825–13830
Yang XZ, Dou S, Wang YC, Long HY, Xiong MH, Mao CQ, Yao YD, Wang J (2012) Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA. ACS Nano 6:4955–4965
Yi Y, Noh MJ, Lee KH (2011) Current advances in retroviral gene therapy. Curr Gene Ther 11:218–228
Zamore PD, Tuschl T, Sharp PA, Bartel DP (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25–33
Zhang WW (1999) Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 6:113–138
Zinselmeyer BH, Mackay SP, Schatzlein AG, Uchegbu IF (2002) The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharm Res 19:960–967
Zuidam NJ, Barenholz Y (1998) Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery. Biochim Biophys Acta 1368:115–128
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Iemsam-Arng, J., Kong, X., Schätzlein, A.G., Uchegbu, I.F. (2013). Gene and Ribonucleic Acid Therapy. In: Uchegbu, I., Schätzlein, A., Cheng, W., Lalatsa, A. (eds) Fundamentals of Pharmaceutical Nanoscience. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9164-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9164-4_18
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9163-7
Online ISBN: 978-1-4614-9164-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)